Zymosan induces nitric oxide production by peritoneal mesothelial cells

ANZ Journal of Surgery

Volumn 74, Issue 4, 2004, Pages 266-269

  Yao, Veronica ^a   McCauley, Rosalie ^a   Cooper, Deborah ^a   Platell, Cameron ^a   Hall, John C ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Cytokines; Peritoneal mesothelial cells; Peritonitis; Zymosan

Indexed keywords

LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; NITRIC OXIDE; NITRITE; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; MALE; MESOTHELIUM CELL; NONHUMAN; PERITONEAL FLUID; PERITONEUM CELL; PERITONITIS; RANDOMIZATION; RAT; SUPERNATANT;

ANIMALS; CELL CULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; MALE; NITRIC OXIDE; PERITONEAL CAVITY; PERITONITIS; RANDOM ALLOCATION; RATS; RATS, WISTAR; ZYMOSAN;

EID: 2442477537     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2004.02952.x     Document Type: Article

References (25)

1. Hall JC, Heel KA, Papadimitriou JM, Platell C. The pathobiology of peritonitis. Gastroenterology 1998; 114: 185-96.
2. Fukatsu K, Saito H, Han I et al. Concomitant increase in neutrophil adhesion to inflammatory peritoneum and remote organs during peritonitis. J. Surg. Res. 1999; 81: 156-63.
3. Douma CE, de Waart DR, Zemel D et al. Nitrate in stable CAPD patients and during peritonitis. Adv. Perit. Dial. 1995; 11: 36-40.
4. Chung-Welch N, Patton WF, Shepro D, Cambria RP. Human omental microvascular endothelial and mesothelial cells: characterization of two distinct mesodermally derived epithelial cells. Microvasc. Res. 1997; 54: 108-20.
5. Bredt DS, Snyder SH. Nitric oxide: a physiologic messenger molecule. Annu. Rev. Biochem. 1994; 63: 175-95.
6. Nathan C, Xie Q. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 1994; 269: 13725.
7. Morris SM, Billiar TR. New insights into the regulation of inducible nitric oxide. Am. J. Physiol. 1994; 266: E829.
8. Combet S, van Landschoot M, Moulin P et al. Regulation of aquaporin-1 and nitric oxide synthase isoforms in a rat model of acute peritonitis. J. Am. Soc. Nephrol. 1999; 10: 2185-96.
9. Combet S, Balligand JL, Lameire N et al. A specific method for measurement of nitric oxide synthase enzymatic activity in peritoneal biopsies. Kidney Int. 2000; 57: 332-8.
10. Albrecht EW, Stegeman CA, Heeringa P et al. Protective role of endothelial nitric oxide synthase. J. Pathol. 2003; 199: 8-17.
11. Gross SS, Wolin MS. Nitric oxide: pathophysiological mechanisms. Annu. Rev. Physiol. 1995; 57: 737-69.
12. Yao V, Cooper D, McCauley R et al. Bacterial translocation in a non-lethal model of peritonitis. Colorectal Dis. 2001; 3: 338-44.
13. Cooper D, Yao V, McCauley R et al. A low morbidity murine model of peritonitis. Dis. Colon Rectum 2002; 45: 394-400.
14. Stylianou E, Jenner LA, Davies M et al. Isolation, culture and characterisation of human peritoneal mesothelial cells. Kidney Int. 1990; 27: 1563-70.
15. Moshage H, Kok B, Huizenga JR, Jansen PLM. Nitrite and nitrate determination in plasma: a critical evaluation. Clin. Chem. 1995; 41: 892-6.
16. Giovannoni G, Land JM, Thompson EJ, Heales SJR. Adaptation of the nitrate reductase and Griess reaction methods for the measurement of serum nitrate plus nitrite levels. Ann. Clin. Biochem. 1997; 34: 193-8.
17. Tadimeti SR, Currie JL, Shaffer AF, Isakson PC. In vivo characterization of zymosan-induced mouse peritoneal inflammation. J. Pharmacol. Exp. Ther. 1994; 269: 917-25.
18. Ajuebor MN, Flower RJ, Hannon R et al. Endogenous monocyte chemoattractant protein-1 recruits monocytes in the zymosan peritonitis model. J. Leukoc. Biol. 1998; 63: 108-16.
19. Coates NJ, McColl SR. Production of chemokines in vivo in response to microbial stimulation. J. Immunol. 2001; 166: 5176-82.
20. Kolaczkowska E, Seljelid R, Plytycz B. Role of mast cells in zymosan-induced peritoneal inflammation in Balb/c and mast cell-deficient WBB6F1 mice. J. Leukoc. Biol. 2001; 69: 33-42.
21. Schierwagen C, Bylund-Fellenius A, Lundberg C. Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity. J. Pharmacol. Meth. 1990; 23: 179-86.
22. Chen JY, Chiu JH, Chen HL et al. Human peritoneal mesothelial cells produce nitric oxide: induction by cytokines. Perit. Dial. Int. 2000; 20: 772-7.
23. Owens MW, Grisham MB. Nitric oxide synthesis by rat pleural mesothelial cells: induction by cytokines and lipopolysaccharide. Am. J. Physiol. 1993; 265: L110-16.
24. Lee SK, Kim JH, Yang WS et al. Exogenous nitric oxide inhibits VCAM-1 expression in human peritoneal mesothelial cells. Role Cyclic GMP and NF-KappaB. Nephron 2002; 90: 447-54.
25. Baldwin AS. The NF-kappa B and I kappa B proteins. Annu. Rev. Immunol. 1996; 14: 649-83.